Showing results (161-170 of 195) with videos related to

Sort By:
Pageof 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Tumor infection by oncolytic reovirus primes adaptive antitumor immunityRobin J Prestwich, Fiona Errington, Elizabeth J Ilett, et al.
International Journal of Radiation Oncology, Biology, Physics|October 14, 2015
Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral ImmunotherapyMiran Blanchard, Kevin G Shim, Michael P Grams, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Repeat Systemic Delivery of Cross-Neutralization Resistant Synthetic Vesiculoviruses Immunomodulates the Tumor MicroenvironmentNatalie M Elliott, Benjamin L Kendall, Souyma Dutta, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 3, 2025
The progressively exhausted T cell response to a poorly immunogenic model of HCC can be partially rescued by immune checkpoint blockade and is heavily suppressed by T cell responses to oncolytic virotherapyThanich Sangsuwannukul, Benjamin Kendall, Jason Tonne, et al.
Nature Communications|June 27, 2024
Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell responseMason J Webb, Thanich Sangsuwannukul, Jacob van Vloten, et al.
Science Translational Medicine|April 13, 2022
Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in miceLaura Evgin, Tim Kottke, Jason Tonne, et al.
Nature Communications|June 26, 2020
Oncolytic virus-derived type I interferon restricts CAR T cell therapyLaura Evgin, Amanda L Huff, Phonphimon Wongthida, et al.
Cancer Immunology Research|April 4, 2019
Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line TreatmentLaura Evgin, Amanda L Huff, Timothy Kottke, et al.
Pageof 20